Clinical trial
Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting
NCT00371215 · ZymoGenetics, Industry · Completed
Key facts
| NCT number | NCT00371215 |
|---|---|
| Title | Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting |
| Official title | A Phase 2 Study of Recombinant Human Thrombin (rThrombin) Administered Using a Spray Applicator in Subjects Undergoing Autologous Skin Grafting Following Burn or Traumatic Skin Injury |
| Lead sponsor | ZymoGenetics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Surgical Hemostasis |
| Intervention type | Biological |
| Interventions | rThrombin |
| Enrollment | 72 |
| Start date | Aug 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 1, 2006 |
| Last update posted | Mar 9, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: